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Early detection of cancer biomarkers can reduce cancermortality rate.miRNAs are small non-coding RNAswhose
expression changes upon the onset of various types of cancer. Biosensors that speciﬁcally detect such biomarkers
can be engineered and integrated into point-of-care devices (POC) using label-free detection, high sensibility and
compactness. In this paper, a new engineered Molecular Beacon (MB) construct used to detect miRNAs is
presented. Such a construct is immobilized onto biosensor surfaces in a covalent and spatially oriented way
using the photonic technology Light Assisted Molecular Immobilization (LAMI). The construct consists of a Cy3
labelled MB covalently attached to a light-switchable peptide. One MB construct contains a poly-A sequence in
its loop region while the other contains a sequence complementary to the cancer biomarker miRNA-21. The
constructs have been characterized by UV-Vis spectroscopy, mass spectrometry and HPLC. LAMI led to the
successful immobilization of the engineered constructs onto thiol functionalized optically ﬂat quartz slides and
Silicon on Insulator (SOI) sensor surfaces. The immobilized Cy3 labelled MB construct has been imaged using
confocal ﬂuorescence microscopy (CFM). The bioavailability of the immobilized engineered MB biosensors was
conﬁrmed through speciﬁc hybridization with the Cy5 labelled complementary sequence and imaged by CFM
and FRET. Hybridization kinetics have been monitored using steady state ﬂuorescence spectroscopy. The label-
free detection of miRNA-21 was also achieved by using integrated photonic sensing structures. The engineered
light sensitive constructs can be immobilized onto thiol reactive surfaces and are currently being integrated in
a POC device for the detection of cancer biomarkers.1 Introduction
The Globocan report pinpoints that in 2018 there were 18.1
million new cancer cases and 9.6 million cancer related deaths
worldwide were registered despite advances in currentalth Science and Technology, Faculty of
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niversity Hospital, Hobrovej 18-22, 9000
mail.com; Tel: +45 2252 2475
edicine, Centre for Biomedical Research
ambelas, 8005-139 Faro, Portugal
tion (ESI) available. See DOI:
3therapies.1,2 The number of new cases is expected to rise by 70%
over the next two decades.3 However, the WHO states that most
cancer types have high cure rates when detected early and
treated according to the best practices. Therefore, early and
trustful detection tools for the implementation of preventive
screening programs are crucial for reducing mortality rates.
Nanotechnology allows the engineering of biosensors with
improved performances and functionalities. In particular,
nanophotonic technology enables the creation of the core
transduction elements of future high-performance biosensors
providing high sensitivity, compactness and high integration
level, shorter time to result, label-free detection, and reduced
sample volumes. In today's point-of-care (POC) market, there is
an ever-increasing demand for novel and more eﬃcient devices
for the early diagnosis of diseases, such as cancer.
New analysis devices for the detection of novel microRNA
(miRNA) biomarkers are most useful and needed. miRNAs are
a class of small non-coding RNAs (z22 nucleotides) whose
dysregulation has been correlated with a growing number of
z400 human diseases,4 including cancer, Alzheimer's, Parkin-
son's, diabetes, osteoporosis and cardiovascular diseases.This journal is © The Royal Society of Chemistry 2019
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View Article OnlineTherefore, the use of miRNA biomarkers will allow the mini-
mally invasive early diagnosis of almost 400 diseases. The
technologies might be adapted to the diagnosis of any other
disease associated with miRNA dysregulation by changing the
probe immobilized on the sensor's surface.
Since the discovery of the loss of miRNA-15a andmiRNA-16-1
in B-cell chronic lymphocytic leukaemia,5 several studies re-
ported changes of miRNA expression in several cancers.6,7
Volinia et al. performed a large-scale miRNome analysis and
identied a large portion of overexpressed miRNAs in solid
tumours,8 being miRNA-21, miRNA-191 and miRNA-17-5p
signicantly overexpressed in all the considered tumour types.
However, they also validated particular miRNA signatures for
each tumour. In recent years, miRNA expression proling has
been able to classify between healthy and tumour tissues and
even between diﬀerent tumour grades.7,9–11 miRNAs have been
found to be extraordinarily stable in plasma and serum
samples.12 Consequently, circulating miRNAs became potential
candidates for blood-based biomarkers. Mitchell et al. showed
that serum levels of miRNA-141 signicantly discriminated
patients with prostate cancer and healthy controls.13 Moreover,
other studies demonstrated the up-regulation of miRNA-21,
miRNA-141, miRNA-200, miRNA-200c, miRNA-200b, miRNA-
203, miRNA-205 and miRNA-214 in circulating cancer exo-
somes.4 Some other miRNAs have also been found in extracel-
lular uids such as plasma serum, saliva and urine.14
The four varieties of cancer with higher incidence and mortality
(z2.7 million deaths worldwide) are: breast, prostate, lung and
colorectal cancers.15 miRNA-21 is overexpressed in most human
tumours, including the abovementioned cancers. Our main goal is
the detection of miRNA-21 using an engineered Molecular Beacon
(MB) probe immobilized on a sensor surface using Light Assisted
Molecular Immobilization (LAMI) technology.16 Two MBs have
been engineered: a model MB comprising a poly-A sequence in its
loop region and aMBwith a sequence complementary tomiRNA-21
in its loop region. Crucial to the success of this work has been the
conjugation of a light activated peptide (KAMHAWGCGGGC-NH2)
to the MB, with tryptophan in close spatial proximity to a disul-
phide bridge (Fig. 1). The peptide enables the immobilization ofFig. 1 Schematic representation of LAMI technology. The MB construct
bridge. The disulﬁde bridge on the peptide is broken upon excitation of th
onto the free thiol groups present on the biosensor support (e.g. SOI).
This journal is © The Royal Society of Chemistry 2019MB-peptide constructs with LAMI technology onto surfaces. LAMI
is a photonic technology that allows for covalent and oriented
immobilization of biomolecules onto thiol reactive surfaces, with
mm and sub-mm spatial resolution.17–23 This photonic technology
presents some advantages over other immobilization tech-
niques24–28 as it does not require chemical or thermal steps to
achieve covalent immobilization and it allows for spatially oriented
immobilization. LAMI makes use of a conserved motif in proteins,
i.e., the close spatial proximity between aromatic residues (trypto-
phan, tyrosine and phenylalanine) and disulphide bridges.16,29,30UV
excitation (275–295 nm) of aromatic residue's side chain induces
electron ejection, which may react with the nearby disulphide
bridge forming of a disulphide electron adduct.31 Such short lived
adduct will dissociate, leading to the formation of free thiol groups
that will covalently bind peptides/proteins to thiol reactive surfaces.
Any molecule can be immobilized with LAMI, even if they do not
display aromatic residues or disulphide bridges, by tagging the
molecule with a small peptide containing such motif.
The present paper shows that LAMI has successfully immo-
bilized MB-peptide constructs onto sensor surfaces which have
successfully hybridized with their respective complementary
oligonucleotide. Non-complementary oligonucleotides have been
used as controls. Hybridization kinetics have been monitored
using steady state uorescence spectroscopy. Detection of the
immobilized MB construct's hybridization with the respective
targets was visualised with confocal uorescence microscopy
(CFM) and using photonic bandgap (PBG) sensing structures. The
use of these PBG structures allows for specic recognition of the
target oligonucleotides through hybridization with the immobi-
lized MB constructs on the surface of the PBG structures in
a label-free and highly sensitive manner. The engineered light
sensitiveMB construct can be immobilized onto any thiol reactive
surface and is being integrated in a photonic sensor device using
the PBG structures for detection. The newly engineeredMBs, their
immobilization and bioavailability are hereby presented. We
hereby demonstrate a proof-of-concept of the feasibility of the new
integrated technology used to detect cancer biomarkers. Further
studies are in progress in order to optimise the sensitivity of the
newly engineered biosensor.is coupled to a peptide which contains a tryptophan nearby a disulﬁde
e nearby tryptophan allowing for covalent bonding of the MB construct
RSC Adv., 2019, 9, 12766–12783 | 12767
Fig. 2 Molecular Beacon sequence (A) and speciﬁcity (B) and chemical synthesis of the Molecular Beacon constructs (C). (A) Molecular
Beacon design (UEA) with the wild type complementary sequence to miRNA-21 showed four base pairs predicted form within the loop (A).
Changing the A at position 21 to a G (red box) removed the internal loop structure to form the desired stem-loop structure (B). (B)
Fluorescence ratio of the MBs containing the wild type complementary sequence for miRNA-21 and with the single base change when
detecting miRNA-21, compared with no miRNA target present (left). MiRNA-21 MB with the single base change could detect the miRNA-21
oligo but not a control oligo of miRNA-140 (right). (C) Engineered MB structures containing diﬀerent oligonucleotide sequences. The MB is
labeled with a ﬂuorescent probe (Cy3) and contains a quencher (DABCYL) in close spatial proximity to the ﬂuorophore when the MB loop is
in its closed form. A peptide is coupled through a linker to the MB structure. This peptide has a disulphide bridge in close proximity to
a tryptophan. This will allow for the LAMI immobilization of the MB constructs to the sensor surfaces. (A) MB structure containing G-G-G-
G-(A)20-C-C-C-C in the loop region. (B) MB structure containing G-G-G-G-TCAA CATC AGTC TGGT AAGC TA-C-C-C-C in the loop
region (oligonucleotide sequence complementary to miRNA21).
12768 | RSC Adv., 2019, 9, 12766–12783 This journal is © The Royal Society of Chemistry 2019
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View Article Online2 Materials and methods
2.1 Materials
The MBs and miRNA-21 oligonucleotide were purchased from
Sigma-Aldrich, UK. KCl, MgCl2 and Tris–HCl were also
purchased from Sigma-Aldrich, UK. The MBs have a 50 6-FAM
uorophore and 30 Black Hole Quencher-1 (BHQ-1),32 which
quenches 6-FAM uorescence. The structure of the designed
MBs is depicted in Fig. 2A.
The two engineered MB constructs (Cy3 labelled), their
complementary and control sequences and the peptide
KAMHAWGCGGGC-NH2 have been purchased from Biosyn-
thesis (Texas, USA). The salts used to make PBS (sodium chlo-
ride, potassium chloride, sodium phosphate dibasic
heptahydrate and potassium phosphate monobasic) were
purchased from Sigma-Aldrich (Missouri, USA).2.2 MB design and validation
MBs were designed with the mFold folding prediction so-
ware.33 Fluorescence based assays using the MBs displayed in
Fig. 2A were performed in white 96-well plates (Fisher, UK) in
buﬀer consisting of 10 mM KCl, 5 mM MgCl2 and 10 mM Tris–
HCl pH 7.5.34 Exposure to light was minimised to reduce uo-
rophore photobleaching and the samples were incubated atFig. 3 Schematic representation of the detection strategies adopted fo
nucleotide sequence, the MB loop will open, allowing for the ﬂuorophore
to an increase of ﬂuorescence intensity emission of Cy3 (top scheme). Aft
with the Cy3 labeled MB construct, the Cy3/Cy5 pair will be in close s
(acceptor) (bottom scheme).
This journal is © The Royal Society of Chemistry 2019room temperature for 10 min before uorescence readings were
taken. Three wells for each condition were used and average
readings were performed to calculate the uorescence ratio
(see, e.g., Fig. 2B), which was calculated using the readings
between wells containing the MB and the target miRNA oligo
UACCACAGGGUAGAACCACGG and the MB alone.
2.3 Engineered MB construct structure
2.3.1 Selection of light activated peptide. The selected
peptide was KAMHAWGCGGGC-NH2, being C cysteine (joined
by a disulphide bridge), K lysine, A alanine, M methionine, H
histidine, W tryptophan and G glycine. Its molecular mass is
z1175 g mol1. UV excitation of the tryptophan leads to the
disruption of the disulphide bridge, enabling the immobiliza-
tion of the MB linked to this peptide onto the thiolized surfaces.
2.3.2 MB construct synthesis and characterization. The
synthesis of the engineered MBs is depicted in Fig. 2C, schemes
1 and 2. The nal construct is shown in Fig. 3 (le). In scheme 1
(Fig. 2C) is depicted the synthesis procedure for the poly-A MB
and in scheme 2 (Fig. 2C) is depicted the procedure for the
miRNA-21 specic MB. The peptide (step [2] and [20] in schemes
1 and 2, respectively) was synthesized following standard solid
phase peptide synthesis procedure to get the cyclized peptide
and puried by RP-HPLC. Amino-C6-modied oligo (compound
[1] in scheme 1 and compound [10] in scheme 2) werer hybridization detection. Upon bonding with a complementary oligo-
to be distanced from the quencher present on the loop stem, leading
er the hybridization of the Cy5 labeled complementary oligonucleotide
patial proximity allowing for energy transfer from Cy3 (donor) to Cy5
RSC Adv., 2019, 9, 12766–12783 | 12769
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View Article Onlinesynthesized followed standard solid phase oligo synthesis
procedure and puried by HPLC. The compounds [1] or [2] were
dissolved into a mixture solution of DMSO–H2O (1 : 2, v/v) and
extra Disuccinimidyl Suberate (DSS) in DMSO was added. The
mixture was incubated for several minutes at room tempera-
ture, precipitated by 30% of NaClO4 in acetone, cooled down at
20 C, and separated by centrifugation. Aer washing with
acetone and drying, the precipitated products [3] or [30] were
dissolved into a mixture solution of DMSO–H2O and extra
peptide [2] in DMSO was added. The reaction mixture was
incubated for 1–2 hours at 37 C and precipitated by 30% of
NaClO4. Aer separation, the crude products [4], [5], or [40] and
[50] were puried by RP-HPLC. The nal product was charac-
terized by Maldi-Tof Mass Spectrometry (MS) on Applied Bio-
system (Model: Voyager DE-Pro; matrix solution: 10 mg mL1 3-
hydroxypicolinic acid and 1 mg mL1 diammonium hydrogen
citrate in water) and the purity was assayed by RP-HPLC on
Beckman (System Gold) and column (Phenomenex, Jupiter,
C18, 300 A˚, 10 m, 150  3.0 mm). The assayed condition was
wavelength: 260; ow rate: 0.8 mL min1; solvent A: 50 mM of
triethylammonium acetate in water and solvent B : acetonitrile;
with a gradient from 20% to 70% of solvent B in 20minutes. The
theoretical molecular weight (MW) was also calculated accord-
ing to:
Theoretical Mw ¼ Mw(oligonucleotide sequence)
+Mw(DSS linker residue) + Mw(peptide) (1)
The calculated MW was correlated to the MW obtained
through MS.
2.3.3 MB-peptide construct structures. The engineered
MBs structure is depicted in Fig. 2C (steps [4], [5] in scheme 1
and [40] [50] in scheme 2, respectively) and illustrated in Fig. 3
(le). The poly-A MB loop region consists of 20 adenosine bases
and 4 G–C base pairs form the stem of the MB (Fig. 2C, scheme
1, step [1]). The loop region of the miRNA-21 specic MB
consists of TCAA CATC AGTC TGGT AAGC TA (Fig. 2C, scheme
2, step [10]). This sequence is complementary to miRNA-21. Both
MBs are coupled to a small peptide linked to one of the strands
of the MBs' stem (Fig. 2C, scheme 1, steps [4] and [5] and
scheme 2, steps [40] and [50]). Cy3 is attached to the 30 end of the
stem, being quenched by DABCYL, located on 50 end of the
stem. When the MB loop is closed (no hybridization), the
presence of DABCYL in close spatial proximity to Cy3 willTable 1 Oligonucleotide sequences used in this study
50 Sequence (50–30) Comments
Cy5 or
unlabelled
GUAGCUUAUCAGACUGAUGUUGAC RNA base, miRNA-21 seq
Cy5 or
unlabelled
GAAAAAAAAAAAAAAAAAAAAAC DNA base, sequence not
MB, this sequence is use
Cy5 or
unlabelled
GTTTTTTTTTTTTTTTTTTTTC DNA base, sequence com
Cy5 or
unlabelled
UACCACAGGGUAGAACCACGG RNA base, miRNA-140 se
(oligonucleotide used as
12770 | RSC Adv., 2019, 9, 12766–12783quench Cy3 emission. When hybridization occurs, the MB loop
opens and Cy3 is separated from DABCYL, becoming
unquenched, increasing the uorescence intensity of Cy3
(Fig. 3, top scheme). The MB loop will only open when there is
binding between the base pairs in the loop and the base pairs in
the target sequence.2.4 Preparation of MB constructs stock solutions
The poly-A MB and the miRNA-21 specic MB constructs were
received in lyophilized form and resuspended in PBS 1 to
a concentration of 10 mM. MB solutions were aliquoted and
stored at 20 C until use.2.5 Preparation of oligonucleotide stock solutions for the
engineered MB constructs
Three diﬀerent oligonucleotide sequences were used in this
study: two sequences are the complementary sequences to poly-
A MB and to miRNA-21 specic MB. The third sequence is
a non-complementary sequence to neither MBs (Table 1). The
oligonucleotides were received in lyophilized form, and with
and without a uorescent label (Cy5), and resuspended in PBS
1 to a concentration of 10 mM. Oligonucleotide solutions were
aliquoted and stored at 20 C until use.2.6 Steady-state uorescence spectroscopy studies –
hybridization kinetics
2.6.1 Presence of tryptophan in the peptide. The excitation
(emission xed at 350 nm) and emission (excitation at 295 nm)
uorescence spectra of a 0.1 mM poly-A MB-peptide sample in
PBS 1 were monitored at room temperature, without stirring,
in a 0.5 mL quartz cuvette. Measurements were performed in
a Felix uorescent RTC 2000 spectrometer (Photon Technology
International, Canada, Inc. 347 Consortium Court London,
Ontario N6E 2S8) with a T-conguration, using a 75 W Xenon
arc lamp coupled to a monochromator.
2.6.2 Hybridization of the MB constructs with the
complementary and control oligonucleotide using unquench-
ing and Fo¨rster resonance energy transfer (FRET). Fluorescence
based hybridization experiments performed with the poly-A MB
constructs were carried out using the non-uorescent oligonu-
cleotide 50-GTTTTTTTTTTTTTTTTTTTTC-30. The detection
strategy is depicted in Fig. 3 (top scheme) has been described in
Section 2.3.3. 300 mL of the poly-A engineered MB samples wereuence complementary to the miRNA21 specic MB sequence.
complementary to the loop region of the model MB and of the miRNA-21
d as a hybridization negative control.
plementary to the model MB sequence.
quence non-complementary to the miRNA21 specic MB sequence
a non-hybridization control on the section MB design and validation).
This journal is © The Royal Society of Chemistry 2019
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View Article Onlineplaced in a 0.5 mL quartz cuvette (0.1 mm optical pathway) at
a nal concentration of 0.1 mM and were illuminated at 548 nm,
monitoring the uorescence emission intensity at 562 nm for
2 min, at room temperature. The experiment was paused and
a solution of the oligonucleotide (30 mL) was added to the poly-A
MB solution (0.1 and 1 mM of complementary oligo were added
to 0.1 mM of poly-A MB). Re-suspension was done with a pipette.
Immediately aer mixing, the solution was continuously illu-
minated at 548 nm and the increase uorescence emission
intensity at 562 nm (unquenching kinetics) was monitored for
1 h, at room temperature.
Hybridization between the miRNA-21 specic MB construct
and the target sequence was monitored through FRET. Cy3 is
present in the MB loop stem and the target oligonucleotides
were Cy5 labelled. The emission spectra of Cy3 (donor) partially
overlaps the excitation spectra of Cy5 (acceptor). When in close
spatial proximity, this spectral overlap allows for energy transfer
from the donor to the acceptor to occur. The spatial proximity
requirement is fullled when hybridization takes place, allow-
ing for the detection of the specic binding between theMB and
the target oligonucleotide (Fig. 3, bottom scheme). Hybridiza-
tion experiments with the miRNA-21 specic MB were carried
out using the Cy5 labelled synthesized oligonucleotide, 50-CAG
UUG UAG UCA GAC UAU UCG AUG-30, complementary the MB's
loop sequence. 300 mL of the miRNA-21 specic MB samples
were prepared in a 0.5 mL quartz cuvette (0.1 mm optical
pathway) at a concentration of 0.1 mM in PBS 1 and illumi-
nated at 488 nm, monitoring the uorescence emission inten-
sity at 670 nm for 2 min, at room temperature. Cy5 absorption is
non-existent at 488 nm, whereas for Cy3 is in the order of 17% of
its maximum absorbance.35 Cy5 uoresces maximally at
670 nm, the wavelength monitored during these experiments.
Thus, the recorded uorescence emission intensity results from
energy transfer between Cy3 (donor) and Cy5 (acceptor).
The experiment was paused and 30 mL of a solution of Cy5
labelled oligonucleotide solution was added to the miRNA-21
specic MB solution (0.1 and 1 mM, respectively). Re-
suspension was done with a pipette. Immediately aer mixing,
the solution was again continuously illuminated at 488 nm and
the uorescence emission intensity at 670 nm was monitored for
1 h, at room temperature. As a non-hybridization control, a 30 mL
of a solution of Cy5 labelled non-complementary oligonucleotide
poly-A was added and the uorescence change was monitored.Fig. 4 Photonic bandgap (PBG) sensing structures. (Left) Schematic repr
miRNA sensing experiments. (Right) Scanning Electron Microscope (SEM
This journal is © The Royal Society of Chemistry 20192.7 Sensor surfaces
Two kinds of sensor surfaces were used to immobilize the light
sensitiveMB constructs: optically at quartz slides and Silicon on
Insulator (SOI) chips (with and without photonic bandgap (PBG)
sensing structures). Optically at quartz slides were purchased
from ArrayIt (SuperClean 2, SCM2) and SOI chips (with and
without PBG sensing structures) were provided by the Universitat
Polit`ecnica de Vale`ncia. The PBG structures present in some of
the SOI chips used in this study are generated by introducing
a periodic modulation in the refractive index of the photonic
structure. In this type of PBG sensing structure, its periodicity
gives rise to the presence of a spectral range where the propa-
gation of the light is forbidden, the so-called photonic bandgap
(PBG). When the refractive index of the surroundings of the PBG
sensing structure will change due to the presence of the target
analytes (themiRNA target in our case), the PBG spectral position
will shi depending on the target analyte concentration.
The photonic chips used in the experiments comprised
several PBG sensing structures of dimensions width w ¼
460 nm, height h ¼ 220 nm, period a ¼ 380 nm and length of
the transversal elements we ¼ 1500 nm. The PBG sensing
structures where organized in pairs, where two diﬀerent widths
of the transversal elements were used for each structure (wi ¼
120 nm and wi ¼ 140 nm). Each chip contained 4 PBG sensor
pairs. The photonic chips were fabricated using e-beam
lithography and inductively coupled plasma etching to trans-
fer the designs to the top silicon layer. An image of one of the
fabricated PBG sensing structures is shown in Fig. 4. Shallow
etch 1D grating couplers where fabricated at the accesses of the
photonic structures in order to vertically couple the light to/
from the chip inputs/outputs. Finally, a top 400 nm-thick SiO2
upper cladding is deposited over the photonic chip in order to
increase the robustness of the photonic structures and to avoid
their damage when the microuidic cell required to ow the
reagents over the chip is placed; a channel is opened in the SiO2
upper cladding in the positions where the PBG sensing struc-
tures are placed in order be in contact with the samples to be
analysed.
2.7.1 Thiolation of sensor surfaces. The surfaces were
chemically modied by silanization according to a method
described elsewhere,16 except that the surfaces were not treated
with chromosulfuric acid prior to silanization.esentation of the PBG sensing structure used to carry out the photonic
) image of one of the PBG sensing structures fabricated in this work.
RSC Adv., 2019, 9, 12766–12783 | 12771
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View Article Online2.8 Illumination setup
A scheme of the experimental system36 is shown in Fig. 5A. The
femtosecond (fs) laser Tsunami XP (Spectra-Physics), is pumped
by the Millennia eV (Spectra-Physics). Typical operation is
around 840 nm with maximum average power of 4 W. The
Tsunami output (100 fs pulses at 80 MHz) is frequency tripled
in a harmonic generation module (Spectra-Physics) to produce
280 nm UV fs pulses with an eﬃciency of 10%. The funda-
mental at 840 nm and the third harmonic at 280 nm are routed
via separate paths into the experimental system. Each beam
passes through a computer controlled variable attenuator con-
sisting of a half-wave plate, mounted in a motorized rotation
stage (PR50CC, Newport) and followed by a polarizing beam
cube. Aer each attenuator, a fused silica beam sampler is used
to direct a portion of the beam onto a photodiode (PD-300R-3W
and PD-300R-UV, OPHIR) for power monitoring. The beam then
passes through safety shutters (LS6S2ZM1, VINCENTFig. 5 Schematic representations of the illumination setup and methodo
UHGmodule and into the UV objective where the 280 nm light is focused
the LAMI procedure carried out using the illumination setup and applied
lization of the MB constructs which will be ready to detect the speciﬁc m
12772 | RSC Adv., 2019, 9, 12766–12783ASSOCIATES) to control exposure to the sample. Only the
280 nm beam has been used in the present study.
2.8.1 Photonic immobilization of MB constructs using
LAMI technology. A droplet of each engineered MB (1 mL) was
placed on the surface of the optically at thiol derivatized
surfaces. Aer drying at room temperature, the sample was
placed in the sample holder of the illumination setup (Fig. 5B).
Samples were illuminated at 280 nm according to an array
pattern (500  500 mm) on the thiol derivatized quartz slides
and according to a line pattern (50 lines with 50 mm separation)
on the thiol derivatized SOI surfaces (without PBG sensing
structures). The patterns were uploaded to the controlling stage
soware in a bitmap image format. Illumination was performed
at 100 mm s1 with a focused laser beam (focused light) through
a 40 UV objective. The illumination power used was 20 or 40
mW. For biofunctionalization of the SOI chips with PBG sensing
structures, a droplet of mi-RNA-21 MB construct was place twology. (A) Schematic description of the laser beam pathway through the
on the sample placed onto themoving sample holder. (B) Illustration of
to the engineered MB. LAMI leads to covalent and oriented immobi-
iRNA targets.
This journal is © The Royal Society of Chemistry 2019
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View Article Onlinepairs of these structures and illuminated continuously for 1 h at
280 nm (diﬀuse light). The remaining pairs of PBG structures
did not contain miRNA-21 specic MB construct and were used
as controls. Aer illumination, the immobilized samples were
washed overnight with PBS 1 plus 0.1% Tween 20 detergent,
rinsed with PBS 1 and dried with compressed air.2.9 Confocal uorescence microscopy (CFM) studies –
uorescent label detection
2.9.1 Imaging the immobilized MB constructs onto opti-
cally at quartz slides and SOI surfaces without PBG sensing
structures. An inverted confocal uorescence microscope
(LEICA TCS SP5) was used to visualize the patterns. To visualize
the immobilized patterns, the immobilized poly-A MB was
excited using the 543 nm laser line form the HeNe laser and Cy3
emission was visualized fromz570 to 650 nm. Even though the
uorophore is quenched by DABCYL when the MBs are immo-
bilised and non-hybridized with the respective complementary
oligonucleotides, their residual uorescence is still detected.
2.9.1 Pattern imaging of immobilized and hybridized MB
construct onto optically at quartz slides and SOI surfaces
without PBG sensing structures. Hybridization of the immobi-
lized patterns of both poly-A MB and of miRNA-21 specic MB
constructs with their respective complementary oligonucleotide
was detected by FRET. The immobilised MB constructs patterns
(labelled with Cy3) were incubated with 10 mM of their respec-
tive oligonucleotide (labelled with Cy5) for 1 h at 37 C. Aer
incubation, the arrays were rinsed with PBS 1 and gently dried
with compressed air. The same procedure was also applied
using a non-complementary oligonucleotide (poly-A sequence).
The arrays were then excited using the 543 nm laser line from
the HeNe laser and emission was imaged by CFM by two
separate PMT's registering emissions fromz570 nm to 650 nm
(Cy3 emission) and from z700 nm to 780 nm (Cy5 emission),
respectively. An overlap of these two emission channels was
carried out to detect co-localization of Cy3 labelled MB and of
Cy5 labelled complementary oligo. Patterns were visualized
through an UV 20 objective.
2.9.3 Photonic-based detection on SOI surfaces with PBG
sensing structures biofunctionalised with miRNA-21 specic
MB construct – label-free detection. The biofunctionalized SOI
chip with PBG sensing structures is assembled with a poly-
dimethylsiloxane (PDMS) ow cell having a ow channel (400
mm-wide and 50 mm-high). This assembled chip is then placed
in an automated optical characterization setup where the
spectral response of all the photonic sensing structures in the
chip is continuously registered. A ber aspheric collimator
(Thorlabs CFS2-1550-APC) is used to couple the light from
a continuous sweep tunable laser (Keysight 81980A) to the
access grating couplers. An infrared (IR) camera (Xenics Xeva-
1.7-320) is used to measure the light from the output grating
couplers, which is collected with an objective (20 Olympus
Plan Achromat, 0.4 NA). The continuous sweep of the laser and
the image acquisition of the IR camera via a trigger signal are
synchronized by a soware programed in LabVIEW which is
able to control the interrogation platform. This synchronizationThis journal is © The Royal Society of Chemistry 2019allows for the acquisition of the spectra of the photonic struc-
tures with the desired spectral resolution.
The conguration for spectra acquisition was set to a range
between 1520 nm and 1620 nm with a sweeping speed of 10 nm
s1 and a spectral resolution of 20 pm. Using a constant ow
rate of 20 ml min1, the target oligonucleotide solutions are
owed using a syringe pump working in withdraw mode.
2.10 Data analysis
All data analysis, plotting and tting procedures were done
using Origin 8.1 (OriginLab Corporation, Northampton, MA,
USA) and MATLAB (MathWorks, Inc. Natick, MA, USA). Fluo-
rescence emission intensity proles and the 3D surface plot of
the immobilized and hybridized MB patterns, imaged by CFM,
were obtained using ImageJ 1.50i.
2.10.1 Emission spectra and excitation spectra. Emission
and excitation spectra were smoothed using a 10 points adja-
cent averaging. All uorescence spectra obtained were Raman
corrected by subtracting the buﬀer spectra. Normalized emis-
sion and excitation spectra were obtained by dividing each data
point by the maximum intensity value in each spectrum.
2.10.2 Hybridization kinetic traces. The hybridization curves
obtained for both poly-A MB and miRNA-21 specic MB were
normalized to their maximum uorescence emission intensity.
2.11 Fitting procedures
2.11.1 Hybridization kinetic traces – emission recorded as
a function of time at 562 nm and 670 nm upon 548 nm
continuous excitation. Each hybridization curve was acquired
upon addition of the complementary oligonucleotide and
monitored upon continuous illumination at 548 nm and
488 nm for 1 h (Fig. 6A and B, respectively). The uorescence
emission intensity data obtained upon addition (at 120 s) of the
complementary oligonucleotide were tted using a double
exponential growth model given by the function F(t) ¼ y0 + A1(1
 exp(x/t1)) + A2(1 exp(x/t2)), where y0 is the oﬀset value, A1
and A2 are the amplitudes and t1 and t2 are the rate constants of
each phase. The errors associated to each parameters and the
root mean square error determined the goodness of the t. The
fractional intensity (fi) of each time constant is given by fi ¼ Aiti/
SiAiti, where Ai is the amplitude (pre-exponential factor) and ti is
the time constant. The mean time constant was calculated
according to hti ¼ Sifiti. These parameters are presented in
Table 2. The hybridization curve obtained for 0.1 mM poly-A MB
+ 1 mM complementary oligonucleotide (poly-T) did not t well
to either a single or double exponential growth model (due to
a fast rise of the curve that led to few points before the plateau
region) thus, no tting is presented. The kinetics for hybrid-
ization of the MB constructs with the respective complementary
oligonucleotide were assumed to follow a two-state mechanism
where [MB] + [complementary oligonucleotide] 4 [MB $
complementary oligonucleotide].
2.12 Image treatment
An area of the CFM images was selected and analysed to obtain
the accumulated average uorescence emission intensityRSC Adv., 2019, 9, 12766–12783 | 12773
Fig. 6 Monitoring the binding kinetics between each MB and its respective complementary oligonucleotide sequence through unquenching (A)
and FRET (B). The following concentration ratios were used: 0.1 mM MB + 0.1 mM complementary oligo (ratio 1 : 1) and 0.1 mM MB + 1 mM
complementary oligo (ratios 1 : 10). The hybridization curves were ﬁtted according to a double exponential growth model F(t) ¼ y0 + A1(1 
exp(x/t1)) + A2(1 exp(x/t2)). The ﬁtted curves are represented in red and the residuals are represented bellow each curve. (A) Binding kinetics
between Cy3 labelled poly-A MB construct and its complementary oligonucleotide sequence (poly-T) monitored by C3 ﬂuorescence emission
intensity signal. (B) Binding kinetics between Cy3 labeled miRNA-21 MB construct and the Cy5 labeled complementary oligonucleotide (miRNA-
21) monitored by C5 ﬂuorescence emission intensity signal. Binding kinetics between Cy3 labeled miRNA-21 MB and Cy5 labelled non-
complementary poly-A was monitored as a non-hybridization control.
RSC Advances Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
5 
A
pr
il 
20
19
. D
ow
nl
oa
de
d 
on
 5
/9
/2
01
9 
3:
07
:0
8 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Onlineproles. These proles result in a 2D display of pixel intensity
along a selected area of the image. For the 3D surface plot, a plot
derived from the pixel intensity displayed in the selected area of
the image was created and adjusted for lighting, perspective
and smoothing.3 Results
3.1 MB selection and validation
MB design showed unwanted base pairing within the loop
(Fig. 2A, le). A single base change was required to open the
structure out into the desired loop to allow access by the target
miRNA-21. As seen in Fig. 2A (right), a mutation of A at position
21 to a G removed this unwanted base pairing, whilst still
retaining the hybridization potential with the T in the miRNA-
21 sequence from G:T pairing. Specicity of the MB for
miRNA-21 was tested by comparing the results using a MB
containing the wild type loop sequence complementary to12774 | RSC Adv., 2019, 9, 12766–12783miRNA-21 against that with the A–G base change necessary to
remove the unwanted base pairing, and a negative control using
an RNA oligo of the unrelated miRNA-140. The concentrations
used were 25 nM of miRNA-21 specic MB and 50 nM of target
miRNA (see paragraph ahead, justifying this choice of concen-
trations). As seen in Fig. 2B (le), opening of the loop with the
single base change makes the MB more able to hybridize with
the target miRNA, with an increase in uorescence ratio of
z8.6%, compared with the MB containing the wild type
sequence. No increase in uorescence ratio was observed when
hybridizing the miRNA-21 specic MB with miRNA-140 (Fig. 2B,
right).
Optimization experiments were performed to nd the
concentration of the MB necessary for uorescence detection of
target miRNA. The uorescence emission intensity of diﬀerent
concentrations of miRNA-21 specic MB (labelled with 6FAM
but without quencher) was monitored and the uorescence
ratio calculated as the uorescence reading of the MB againstThis journal is © The Royal Society of Chemistry 2019
Table 2 Parameters obtained according to the double exponential ﬁtting model F(t) ¼ y0 + A1(1  exp(x/t1)) + A2(1  exp(x/t2))a
Y oﬀset Rate constant (s1) Fractional intensity (%) Amplitude
Poly-A MB (unquenching)
Poly-A MB + poly-T oligo (1 : 1)
y0 ¼ 19.323  1.116 t1 (slow phase) ¼ 465.272  6.453 f1 ¼ 6 A1 ¼ 0.081  0.001
t2 (fast phase) ¼ 27.757  0.326 f2 ¼ 94 A2 ¼ 20.240  1.115
hti ¼ 55.262
miRNA-21 MB (FRET)
miRNA-21 MB + miRNA-21 oligo (1 : 1)
y0 ¼ 0.021  0.004 t1 (slow phase) ¼ 1120.800  9.225 f1 ¼ 83 A1 ¼ 0.499  0.003
t2 (fast phase) ¼ 210.142  2.496 f2 ¼ 17 A2 ¼ 0.543  0.003
hti ¼ 966.487
miRNA-21 MB + miRNA-21 oligo (1 : 10)
y0 ¼ 13.896  4.721 t1 (slow phase) ¼ 126.854  1.374 f1 ¼ 22 A1 ¼ 0.784  0.019
t2 (fast phase) ¼ 24.449  1.750 f2 ¼ 78 A2 ¼ 14.111  4.706
hti ¼ 47.366
a Y oﬀset (y0), amplitude (Ai), rate constants (ti), intensity fraction (fi) and average rate constant (hti) for hybridization of poly-A and miRNA-21
specic MB constructs with the respective complementary oligonucleotides (ratios 1 : 1 and 1 : 10).
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View Article Onlinethat of the assay buﬀer (Fig. S1A†). For further optimizations,
25 nM of 6-FAM labelled miRNA-21 specic MB was used since
the uorophore emission intensity was clearly detectable. To
optimize the concentration of miRNA oligo in the assay, 25 nM
of MB and a range of miRNA concentrations from 25–1000 nM
were used. As shown in Fig. S1B† miRNA oligo at 50 nM and
above produced uorescence ratios clearly detectable above
those of the MB or assay buﬀer alone. For further experiments,
25 nMMB and 50 nMmiRNA oligo were used (Fig. 1, scheme 3).3.2 Engineered MB constructs: synthesis and
characterization
The purity level of the MB coupled to the peptide obtained by
HPLC was >96% for the poly-A MB construct and >97% for the
miRNA-21MB construct (Fig. S2†). TheMW of theMB constructs
was determined by MS (Fig. S3†). Data obtained for the poly-A
MB construct (Fig. S3,† upper panel) shows a clearly dened
peak corresponding to a MW of 11 384.78 Da, matches the
theoretical MW (11 384.84 Da). The same was observed for the
MS data obtained for the miRNA-21 construct (Fig. S3,† lower
panel), where a sharp peak shows a MW of 12 001.09 Da, which
matches the calculated MW (12 000.16 Da).3.3 Steady state uorescence studies – hybridization kinetics
3.3.1 Presence of tryptophan in the peptide construct. In
Fig. S4† are depicted the uorescence excitation and emission
spectra of the poly-A MB upon excitation at 295 nm and xed
emission at 350 nm. The uorescence emission spectrum
presents maximum intensity peak at 353 nm, whereas the
maximum uorescence intensity peak of the excitation spectra
is at 298 nm. These spectral features are characteristic of tryp-
tophan, proving its presence in the tag construct.
3.3.2 Hybridization studies using poly-A and miRNA-21
specic MB constructs. In Fig. 3 is depicted the strategy used
for the detection of the target miRNA by the MB constructs (asThis journal is © The Royal Society of Chemistry 2019explained in Section 2.6.2). The binding kinetics between the
poly-A MB and the respective complementary non-labelled
oligonucleotide were studied at diﬀerent concentrations: 0.1
and 1 mM of complementary oligonucleotide poly-T were added
to 0.1 mM of poly-A MB (ratios 1 : 1 and 1 : 10, respectively). The
binding kinetics were monitored following the increase of
uorescence emission intensity as a function of time aer
adding the complementary oligonucleotide to the poly-A MB
solution. The MB loop opens upon binding with the comple-
mentary oligonucleotide resulting in an increase of Cy3 emis-
sion due to separation between the uorophore (Cy3) and the
quencher (dtDABCYL), (Fig. 3A). In Fig. 6A are displayed the
kinetic curves obtained upon monitoring the uorescence
emission intensity of Cy3 (lexcitation ¼ 548 nm, lemission ¼ 562
nm) and the respective tted curve for the hybridization at
a ratio of 1 : 1. The tting parameters are described in Table 2.
The residual values for this tting are randomly distributed
around 0 (Fig. 6A, lower panel).
The hybridization curve obtained for ratio 1 : 1 demonstrates
a fast phase with a rate constant of 27.757  0.326 s1 and an
amplitude of 20.240 1.115 followed by a slow phase with a rate
constant of 465.272  6.453 s1 and an amplitude of 0.081 
0.001. The calculated fractional intensity for the fast rate
constant was 94% and for the slow rate constant was 6%. Thus,
the average rate constant obtained for this ratio was 55.3 s1,
indicating a reaction where the [MB $ complementary oligo-
nucleotide] equilibrium is reached fast. Increasing the ratio to
1 : 10, the reaction rate is much faster (Fig. 6A, blue dotted
lines). A good tting was not achieved for the hybridization
curve obtained at the ratio 1 : 10, however the curve shape
shows a fast increase of uorescence intensity reaching
a plateau within z150 s.
The binding kinetics between the miRNA-21 specic MB and
its respective complementary oligonucleotide were monitored
through FRET between Cy3 (stem of the MB loop) and Cy5
(complementary oligonucleotide) (Fig. 3B). In Fig. 6B isRSC Adv., 2019, 9, 12766–12783 | 12775
RSC Advances Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
5 
A
pr
il 
20
19
. D
ow
nl
oa
de
d 
on
 5
/9
/2
01
9 
3:
07
:0
8 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Onlinedepicted the binding curve between the miRNA-21 specic MB
and the oligonucleotide at diﬀerent concentrations: 0.1 and 1
mM of oligonucleotide miRNA-21 were added to 0.1 mM of
miRNA-21 specic MB (ratios 1 : 1 and 1 : 10, respectively). The
increase of uorescence emission intensity of Cy5 is monitored
as a function of time (lexcitation ¼ 488 nm, lemission ¼ 670 nm)
before and aer adding the oligonucleotide. The respective
tted curves are also depicted in Fig. 6B and the derived tting
parameters can be found in Table 2. The residual values for
these tting are randomly distributed around 0 (Fig. 6B, lower
panels).
The curve obtained for the hybridization of the miRNA-21
specic MB with the complementary oligonucleotide at a ratio
of 1 : 1 shows an initial fast phase with a rate constant of
210.142 2.496 s1 and an amplitude of 0.543 0.003 followed
by a slower phase with a rate constant of 1120.800  9.225 s1
and an amplitude of 0.499  0.003. However, at a ratio of 1 : 10,
the obtained fast rate constant was 24.449  1.75 s1 with an
amplitude of 14.111  4.71 and the slower rate constant was
126.854  1.37 s1 with an amplitude of 0.784  0.02. At ratio
(1 : 1), the calculated fractional intensity is higher for the slow
rate constant (83%) whereas at a ratio of 1 : 10, the higher
calculated fractional intensity was obtained for the fast rate
constant (78%). Thus, the obtained average rate constants for
ratios 1 : 1 and 1 : 10 were 966.5 s1 and 47.4 s1, respectively.
This indicates that at the lower molar ratio of 1 : 1, the [MB $
complementary oligonucleotide] equilibrium (plateau region) is
reached at a slower pace, as expected. However, the diﬀerence
registered between ratios for the miRNA-21 specic MB (Fig. 6B)
hybridization is much higher then what is observed for the poly-
A MB (Fig. 6A). The uorescence emission intensity of miRNA-
21 specic MB upon addition of a non-complementary poly-A
oligonucleotide was also monitored (Fig. 6B, black dashed
line). No hybridization occurs, as expected.3.4 Photonic immobilization using LAMI and visual
detection using CFM – uorescent label detection
3.4.1 Photonic immobilization of poly-A MB construct onto
optically at thiol derivatized quartz surfaces. The poly-A MB
construct was illuminated with 280 nm light according to an
array pattern using the laser system setup described in Section
2.8. Aer overnight washing, the array was visualized by CFM
and is depicted in Fig. 7A. It is possible to observe that the poly-
A MB construct was successfully immobilized according to an
array pattern (500  500 mM). A 3D projection of the immobi-
lized array is shown in Fig. 7B. In this analysis, the area con-
taining the immobilized array was selected (yellow lines). The
soware creates an interactive surface plot, where the height of
the plot is interpreted from the pixel intensity of the selected
area. Spatially well-dened and homogeneous uorescence
emission intensity distribution among spots is observed. In
Fig. 7C is depicted the accumulated average uorescence
emission intensity distribution across the MB construct
immobilized array. The average intensity prole is plotted as
pixel intensity (a.u.) as a function of distance (in pixels) in the
selected area (yellow lines). The intensity prole is periodic,12776 | RSC Adv., 2019, 9, 12766–12783with sharp peaks with homogeneous distribution and approxi-
mately the same intensity. A total of 18 peaks are observed in
this average uorescence emission intensity prole, correlating
to each vertical line of the immobilized poly-A MB construct
array.
3.4.2 Hybridization of the complementary oligonucleotide
sequences to LAMI immobilized MB constructs (poly-A and
miRNA-21 specic MB constructs) onto optically at thiol
derivatized quartz surfaces. Immobilization of the miRNA-21
specic MB construct was also carried out and the bioavail-
ability of both poly-A and miRNA-21 MB constructs was tested
through visualization of co-localization of the immobilized MB
constructs and the respective complementary oligonucleotides
by FRET.
The hybridization of immobilized poly-A MB and mi-RNA
specic MB constructs with their respective complementary
oligonucleotides can be observed in Fig. 8A and 9A. The uo-
rescence intensity emission of both Cy3 (lem fromz570 nm to
650 nm, present in the MBs) and Cy5 (lem from z700 nm to
780 nm, present in the complementary oligonucleotides) was
monitored upon excitation at 543 nm (Cy3 excitation wave-
length). In Fig. 8A and 9A are depicted Cy3 emission (le) for the
immobilized poly-A MB and miRNA-21 MB constructs, respec-
tively, and Cy5 emission (center) for the respective comple-
mentary oligonucleotides. Fig. 8A and 9A (right panels) were
obtained through an overlap of the respective Cy3 and Cy5
emissions images. Both emissions are spatially overlapped,
revealing co-localization of both uorophores and thus,
hybridization between the immobilized MB constructs and
their respective complementary oligonucleotides. An average
uorescence emission intensity prole was obtained for each of
the individual images as well as a 3D plot of the co-localization
images (Fig. 8B and 9B). The confocal uorescence images ob-
tained for the immobilized poly-A MB array (Cy3 emission,
Fig. 8A, le panel) and for the hybridization with the respective
complementary poly-T oligonucleotide (Cy5 emission, Fig. 8A,
center panel) show a clear prole with sharp and dened peaks
(Fig. 8B, le and center panels). The 3D plot of the co-localized
Cy3 and Cy5 emissions also shows a dened array pattern, with
a homogeneous distribution of the spots inside the array
(Fig. 8B, right panel). The array images obtained for the
immobilized miRNA-21 specic MB construct (Cy3 emission)
and for the hybridized complementary oligonucleotide (Cy5
emission) appear less dened (Fig. 9A, le and center panel,
respectively) but the array pattern is still perceptible. The
average uorescence emission intensity prole analysis (Fig. 9B,
le and center panel, respectively) reveals the presence of peaks
periodically distributed, which location is correlated with each
vertical line of the array pattern. These peaks are well dened
but less spatially resolved than the peaks observed for the
average intensity prole of the images obtained from both the
immobilized poly-A MB constructs and the hybridized poly-A
MB with its respective complementary oligonucleotide. The
3D plot of the overlapped Cy3 and Cy5 images (immobilized MB
construct and complementary oligonucleotide, respectively)
shows the co-localization between the immobilized miRNA-21
specic MB and the respective complementary oligonucleotideThis journal is © The Royal Society of Chemistry 2019
Fig. 7 Analysis of a LAMI immobilized poly-A MB array onto a SH derivatized quartz surface. (A) CFM image of poly-A MB construct immobilized
according to an array pattern (20 ampliﬁcation). (B) 3D surface plot obtained from the analysis of pixel intensity under the selected area in A
(yellow box). (C) Correspondent average Cy3 ﬂuorescence emission intensity proﬁle of array in A.
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View Article Online(Fig. 9B, right panel). However, as observed for the individual
Cy3 and Cy5 emission images, the spots inside the array pattern
are homogenously distributed but poorly resolved, with some
background noise between spots.
3.4.3 Control experiments. The same experiments were
carried out with the immobilized Cy3 labelled poly-A MB and
miRNA-21 specic MB constructs, being the hybridization
carried out with the non-complementary Cy5 labelled oligo-
nucleotide strand (poly-A). Cy3 emission is the only observed
signal upon excitation of Cy3 (Fig. S5 and S6,† le and right
panels). A faint uorescence signal was detected when exciting
Cy3 and specically opening the detector to detect Cy5 emis-
sion (Fig. S5 and S6,† middle panels). This proves that
hybridization was not successful and no co-localization
between the two uorophores was visible (Fig. S5 and S6†).
3.4.4 Photonic immobilization of poly-A MB andmiRNA-21
specic MB constructs on thiol derivatized SOI surfaces
(without PBG sensing structures). The poly-A MB and the
miRNA-21 specic MB constructs were placed on a thiol
derivatized SOI surface and illuminated at 280 nm accordingThis journal is © The Royal Society of Chemistry 2019to a line pattern (50 lines, 50 mM separation). In Fig. 10 A1 and
B1 are depicted part of the immobilized lines pattern of both
MB constructs, observed by CFM. Due to the large size of the
arrays, only a portion of each array is visible in the eld of view
of each image. In Fig. 10A2 and 10B2 are depicted the average
uorescence emission intensity proles obtained from
Fig. 10A1 and 10B1, respectively. Both MB constructs were
successfully immobilized onto the thiol derivatized SOI
surface. The line pattern of the immobilized poly-A MB
construct appears less intense and with thinner lines than the
pattern of immobilized miRNA-21 specic MB construct
because the light was more focused upon immobilization. The
overall uorescence emission intensity distribution of the
immobilized patterns is more homogeneous for the immobi-
lized miRNA-21 specic MB construct (see intensity prole
images, Fig. 10A1 and A2). However, for both immobilized MB
constructs the peaks appear to be sharp and well dened with
a periodic distribution, correlating well with the dened line
pattern visualized.RSC Adv., 2019, 9, 12766–12783 | 12777
Fig. 8 Bioavailability analysis of a LAMI immobilized poly-AMB arrays onto SH derivatized quartz slides. (A) CFM images of Cy3 labeled poly-AMB
constructs ﬂuorescence (left), Cy5 labeled hybridized complementary oligonucleotide ﬂuorescence (centre) and co-localization of Cy3 and Cy5
ﬂuorescence emission (right). (B) Average ﬂuorescence emission intensity proﬁles of the images in A displayed for Cy3 and Cy5 ﬂuorescence (left
and centre) and 3D surface plot of co-localized Cy3 and Cy5 ﬂuorescence emission (right).
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View Article Online3.4.5 Hybridization of the complementary oligonucleotide
sequence to LAMI immobilized miRNA-21 specic MB
construct onto thiol derivatized SOI surfaces (without PBG
sensing structures). The miRNA-21 specic MB construct was
illuminated and immobilized onto the SOI surfaces according to
a line pattern (see Section 3.4.4.) and hybridized with the target
oligonucleotide. The emissions of both the immobilized MB (Cy3
emission) and of the target oligonucleotide (Cy5 emission) were
acquired upon excitation at 543 nm (Cy3 excitation) (see Fig. 11A).
It is possible to observe the uorescence of the immobilized MB
construct according to a line pattern in the rst image (Cy3
emission, le panel) as well as the hybridized complementary
oligonucleotide in the second image (Cy5 emission, middle panel).
In both images, a dened pattern is observed.
An overlap of both images (Cy3 and Cy5 emissions) was also
performed (Fig. 11A, right panel). The co-localization of the
immobilized MB construct and the uorescently labeled oligo-
nucleotide is observed, proving successful hybridization. The
3D plot also shows the overlap, maintaining the resolution of
the immobilized pattern and showing that both the immobili-
zation and the hybridization took place in a spatially oriented
manner (Fig. 11B).3.5 Photonic immobilization with LAMI of miRNA-21
specic MB construct photonic-based detection on SOI
surfaces with PBG sensing structures – label-free detection
Once the immobilization of the MB probes was tested on SOI
surfaces and the detection of their complementary miRNA12778 | RSC Adv., 2019, 9, 12766–12783targets was successfully validated by means of uorescence-
based measurements, a photonic-based detection experi-
ment was performed using nanophotonic sensing structures
fabricated on those SOI substrates. To this aim, a photonic
chip having several photonic bandgap (PBG) sensing struc-
tures (Fig. 4) was used. The photonic sensing chips were bio-
functionalised using the LAMI immobilization protocol with
diﬀuse irradiation of the sample instead of focused light. The
miRNA-21 specic MB construct was immobilized in two of the
PBG sensors pairs while leaving another PBG sensors pair free
(i.e., with the organosilane on the surface, but no irradiated
miRNA-21 specic MB construct on it). Fig. 12 shows the
sensing response for some representative PBG sensing struc-
tures on the chip. It can be observed that the PBG sensing
structures having the MB construct immobilized are able to
detect the presence of the specic target miRNA-21 (red and
blue lines), while no sensing response was obtained for that
PBG sensor where the MB probe has not been immobilized
(green line). The signal obtained for miRNA-21 detection was
higher (z4) for the structure with wider transversal
elements (wi ¼ 140 nm, red line) than the signal obtained for
miRNA-21 detection from the narrower transversal elements
(wi ¼ 120 nm, blue line). Therefore, we can see that the
physical parameters of the PBG sensing structure have
a dramatic inuence on the sensitivity, obtaining a sensing
signal 4 times higher for the structure having wider trans-
versal elements on the PGB sensing structure (red line), what
highlights the importance of a proper design in order to obtain
an optimized sensitivity.This journal is © The Royal Society of Chemistry 2019
Fig. 9 Bioavailability analysis of a LAMI immobilized miRNA-21 speciﬁc MB arrays onto SH derivatized quartz slides. (A) CFM images of Cy3
labeled miRNA-21 MB constructs ﬂuorescence (left), Cy5 labeled hybridized complementary oligonucleotide ﬂuorescence (centre) and co-
localization of Cy3 and Cy5 ﬂuorescence images (right). (B) Average ﬂuorescence emission intensity proﬁles corresponding to the images in C
displayed for Cy3 and Cy5 ﬂuorescence (left and centre) and 3D surface plot of co-localized Cy3 and Cy5 ﬂuorescence images (right).
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View Article Online4 Discussion
4.1 Steady state uorescence studies – hybridization kinetics
The presence of tryptophan in the peptide construct and its
proximity to the disulphide bridge is crucial for LAMI. Upon
280 nm excitation, tryptophan undergoes photoionization. The
resulting ejected electron is most likely to react with nearby
disulphide bridges.31 A disulphide electron adduct is formed
which dissociates, leading to the breakage of the disulphide
bridge. As a result, free thiol group(s) will be formed, which
covalently bind to thiol derivatized surfaces,17,30 enabling the
spatially oriented immobilization of the MB constructs. The
monitored emission spectra upon excitation at 295 nm (wave-
length for selective excitation of Trp) displayed a maximum
intensity peak at 353 nm. Tryptophan has an emission
maximum in water close to 350 nm, being its emission highly
dependent on solvent polarity and the surrounding environ-
ment.37 Thus, the presence of this amino acid residue in the
peptide was conrmed (see Fig. S4†).
The hybridization rate of poly-A MB (Fig. 6A) and miRNA-21
specic MB (Fig. 6B) constructs with their respective targets is
concentration dependent. In general, an initial fast binding
phase is observed at all ratios followed by a slower phase until
equilibrium is reached. For higher concentrations of oligonu-
cleotide (ratio 1 : 10), this initial phase is almost immediate and
equilibrium is reached within minutes (z2.5 min for poly-A MB
and z 6 min for miRNA-21 specic MB). For lower MB/This journal is © The Royal Society of Chemistry 2019oligonucleotide ratio (1 : 1), this equilibrium is reached at
z25 min for poly-A MB but for the miRNA MB it can take up to
60 min. Hybridization consists of three steps which, in most
cases, happens simultaneously: (a) the target binds to the MB
probe domain which remains in a closed loop; (b) the loop
opens as the number of bound base pairs increases; (c) binding
of target base pairs to the remaining base pairs in the MB.34 It is
reasonable to assume that the hybridization rate is faster in the
presence of an excess of oligonucleotide as there is a higher
probability for the target sequence to nd the MB loop. As
concentrations are lowered, steps (a) and (b) are dependent on
target sequence/MB loop proximity which might reduce the
speed at which these two events occur. Steps (a) and (b) are then
the limiting steps for the hybridization reaction and the pres-
ence of Cy3 at the stem of the MB does not aﬀect the hybrid-
ization rate.34
The length of theMB stem also inuences the speed at which
step (a) occurs. In this study, both poly-A MB and miRNA-21
specic MB have a stem composed of 4 GC base pairs.
However, the miRNA-21 specic MB possesses an extra A–T
pairing at the stem from the miRNA-21 specic loop. The
observed binding kinetics is 17.5 faster for the poly-A MB and
its target sequence at a ratio of 1 : 1 (Table 2) when compared
with the miRNA-21 MB and its target at a ratio of 1 : 1. This
might be due to the simplicity of the sequence as it is composed
of a single nucleotide repetition, making it easier for binding to
occur. Also, it might be due to the extra A–T pairing in the stemRSC Adv., 2019, 9, 12766–12783 | 12779
Fig. 10 Analysis of LAMI immobilized poly-A and miRNA-21 MB speciﬁc patterns onto SH derivatized SOI surfaces. (A1) CFM image of Cy3
ﬂuorescence emitted by the immobilized poly-A MB construct, according to a line pattern. (A2) Average ﬂuorescence emission intensity cor-
responding to the immobilized pattern in A1 under the selected area (yellow square). (B1) CFM image of Cy3 ﬂuorescence emitted by the
immobilized miRNA-21 speciﬁc MB construct, according to a line pattern. (B2) Average ﬂuorescence emission intensity corresponding to the
immobilized pattern in B1 under the selected area (yellow square).
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View Article Onlineof the miRNA-21 specic MB. Nonetheless, the hybridization of
the two MBs with their respective complementary oligonucleo-
tide was monitored by two diﬀerent uorescence emission
processes (unquenching and FRET), which might also inuence
the observed result.4.2 Photonic immobilization with LAMI and visual detection
of hybridization by CFM
The poly-A MB construct immobilization was successful (Fig. 7)
and a spatially oriented immobilization was achieved due to the
spatially controlled illumination.
The immobilized poly-A MB construct presents a closed loop
conformation, as it has not been exposed to its target sequence.
This means that the uorescence emission of the MB in this
state is less intense than when in the open form due to the close
spatial proximity of DABCYL (quencher) to Cy3, both present in
the stem of the loop (see Fig. 3). However, even in the quenched
form, Cy3 uoresces, allowing the visualization of the immo-
bilized array (see Fig. 7). Such residual Cy3 uorescence emis-
sion was also observed in the initial baseline monitored during
the hybridization studies (Fig. 6).
Even though the presence of background uorescence has
been a drawback in the past,38 data showed that there was
a good signal-to-background ratio upon hybridization with the
target sequence (S/N ratio below 14.5 for hybridization with12780 | RSC Adv., 2019, 9, 12766–12783miRNA-21 specic and below 3.8 for hybridization with poly-A
MB). Furthermore, previous data of immobilized poly-A MB
construct showed the increase in the array's uorescence
emission signal upon hybridization with the target sequence
due to unquenching.36 Successful hybridization of the immo-
bilized MB constructs with the target oligonucleotide sequences
was also done using FRET (Fig. 8, 9, 10 and 11), both on opti-
cally at thiol derivatized quartz and thiol derivatized SOI
surfaces.
The SOI derivatized surfaces are to be integrated in a POC
diagnostic device. LAMI presents some advantages over other
traditional immobilization techniques. Conventional tech-
niques cannot achieve spatially oriented immobilization of
biosensors nor can they assure an immobilized homogeneous
monolayer.39 LAMI is able to achieve covalent immobilization
of biosensors in a spatially oriented manner, avoiding the
crowding eﬀect that hinders hybridization due to high density
of the immobilized probes.39 Also, LAMI presents high repro-
ducibility and allows for immobilization of proteins, anti-
bodies and MB constructs without compromising the
bioavailability of the immobilized biosensors. Furthermore, it
does not require high temperatures for hybridization to
occur39 as the hybridization results presented in this paper
were obtained at room temperature. Although LAMI uses
280 nm light to achieve immobilization, it does not hinder the
biosensors ability to recognize their analytes. UVB light (280–This journal is © The Royal Society of Chemistry 2019
Fig. 11 Bioavailability analysis of LAMI immobilized miRNA-21 speciﬁc MB patterns onto SH derivatized SOI surfaces. (A) CFM image of a Cy3
labeled miRNA-21 speciﬁc MB construct line array (left), ﬂuorescence emission from the Cy5 labeled and hybridized complementary oligo-
nucleotide ﬂuorescence (centre) and co-localization of Cy3 and Cy5 ﬂuorescence images (right). (B) 3D surface plots of Cy3 labeled miRNA-21
speciﬁcMB construct line array (left), Cy5 emission from the hybridized complementary oligonucleotide (centre) and of the co-localized Cy3 and
Cy5 emitted ﬂuorescence (right).
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View Article Online315 nm) has been reported to cause damage to DNA. Deami-
nation of bases, depyrimidination and depurination as well as
formation of free radicals or reactive oxygen species are some
of the UV induced possible changes.40 However, both immo-
bilized MBs were capable of recognizing the target sequences.
Illumination time applied for the immobilization of MB
patterns was very short (ms), as the velocity of the moving
stage upon illumination was of 100 mm s1. Thus, the
hybridization between the target sequences and the immobi-
lized MB constructs hereby reported was not hindered by the
immobilization process.
The excitation wavelength chosen (laser line at 543 nm) for
CFM imaging was close to the maximum excitation wavelength
described for Cy3 (z548 nm) and the monitored emission
wavelengths correspond to intervals where both Cy3 and Cy5
emit, respectively. At 700 nm (approximate lower limit of the
interval in which Cy5 uorescence emission was monitored),
there is almost no uorescent emission for Cy3 (z2% relative to
its maximum absorption intensity) whereas for Cy5 the uo-
rescence emission intensity at this wavelength is z28%.
Furthermore, at the excitation wavelength selected, Cy5 has
only a residual absorption of 6% (compared to its maximum
absorption intensity).35 As a consequence, the monitored uo-
rescence emission intensity is mainly due to FRET, even though
some background uorescence might be visible in the wave-
length interval monitored for Cy5 emission. Control experi-
ments where the immobilized Cy3 labelled poly-A MB construct
was hybridized with a Cy5 labelled non-complementary oligo-
nucleotides (poly-A oligonucleotide) show that there is no Cy5This journal is © The Royal Society of Chemistry 2019emission (upon Cy3 excitation) (Fig. S5†). When using the
miRNA-21 MB construct, a faint residual Cy5 signal can be
observed (Fig. S6†).
The focal distance also inuences the pattern spatial distribu-
tion. Fig. 10A1 and B1 show a diﬀerence in the thickness of the
lines in the immobilized patterns. Although both arrays were
designed under the same conditions, a small diﬀerence in the
focal distance inuences the immobilized pattern. The pattern
immobilized with more focused light displays lines with z5 mm
width whereas the pattern immobilized with less focused light
displays lines with a width ofz17 mm, even though both patterns
present a distance between lines of 50 mm, as specied in the
design. All MB constructs were immobilized with mm resolution.4.3 Photonic immobilization with LAMI and photonic-based
detection on SOI chips with PBG sensing structures – label-
free detection
The detection of LAMI immobilized miRNA-21 specic MB
using PBG structures was successful. However, it was observed
that the sensitivity of detection is dependent on physical
parameters such as the width of the transversal elements of the
sensing structures and also the presence of SiO2 in these
structures. As the PBG sensing structures need to be in contact
with the medium to be analysed, windows are opened in the
SiO2 upper cladding just in the positions where they are placed
by UV lithography and etching of the SiO2. Aer opening these
windows, a more robust photonic chip is obtained, but the
presence of some SiO2 residues in the walls of the PBG sensing
structures produces a decrease of its sensitivity. This trade-oﬀRSC Adv., 2019, 9, 12766–12783 | 12781
Fig. 12 Spectral evolution of the PBG edge position for the sensing structures within the photonic chip when the target miR-21 is ﬂowed over
their surface. The sensing response for PBG sensor is depicted in a diﬀerent color.
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View Article Onlinebetween chip robustness and sensitivity needs to be overcome
in future sensing chips developments. The physical parameters
of the PBG sensing structure also have a dramatic inuence on
the sensitivity. The acquired sensing signal for the structure
having wider transversal elements of the PGB sensing structure
was 4 times higher (Fig. 12, red line) than the signal obtained
for the narrower transversal elements of the PBG sensing
structure (Fig. 12, blue line). This sensitivity diﬀerence is higher
than what it might be expect (around 1.5 from previous
experiments), possibly due to the non-uniform presence of the
SiO2 residues from the upper cladding layer. Nanophotonic
sensing technology is characterized by a very high sensitivity,
which comes from the high interaction occurring between the
light conned in the photonic structures and the target analytes
in a reduced size structure. Additionally, the type of PBG
sensing structures used in this work have demonstrated an even
higher sensitivity,41 which is determined by the appearance of
the so-called slow-wave behavior that induces a more eﬀective
interaction with the target analyte during a longer time.5 Conclusions
The new MB constructs presented in this paper were able to
recognize target sequences in vitro. One of such sequences is
a biomarker for colon and breast cancer. The recognition ach-
ieved by the two MB constructs was assessed by two diﬀerent
uorescence recognition methods. These constructs were
successfully immobilized onto thiol reactive surfaces using
LAMI. LAMI presents some advantages over more conventional
immobilization techniques as it allows for immobilization in
spatially oriented and covalent manner and with mm resolution
(sub-mm resolution can also be achieved).22,23 Biosensors
bioavailability is not compromised by the UV light used for
immobilization, making these biosensors and LAMI suitable to
produce arrays for integration in POC diagnostic devices and
used in this specic project for the detection of cancer
biomarkers.12782 | RSC Adv., 2019, 9, 12766–12783Conﬂicts of interest
The authors declare no conicts of interest.
Acknowledgements
This work was supported by the European Commission through
the project H2020-644242 – SAPHELY and the project H2020-
634013-2-PHOCNOSIS.
References
1 New Global Cancer Data: GLOBOCAN 2018|UICC, https://
www.uicc.org/new-global-cancer-data-globocan-2018,
accessed 14 December 2018.
2 WHO|Cancer, http://www.who.int/cancer/en/, accessed 14
December 2018.
3 WHO|Cancer, http://www.who.int/mediacentre/factsheets/
fs297/en/, accessed 16 August 2017.
4 Y. Li, C. Qiu, J. Tu, B. Geng, J. Yang, T. Jiang and Q. Cui,
HMDD v2.0: a database for experimentally supported human
microRNA and disease associations, https://
academic.oup.com/nar/article-lookup/doi/10.1093/nar/
gkt1023, accessed 16 August 2017.
5 G. A. Calin, C. D. Dumitru, M. Shimizu, R. Bichi, S. Zupo,
E. Noch, H. Aldler, S. Rattan, M. Keating, K. Rai,
L. Rassenti, T. Kipps, M. Negrini, F. Bullrich and
C. M. Croce, Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 15524–
15529.
6 M. D. Jansson and A. H. Lund, Mol. Oncol., 2012, 6, 590–610.
7 Y. S. Lee and A. Dutta, Annu. Rev. Pathol., 2009, 4, 199–227.
8 S. Volinia, G. A. Calin, C.-G. Liu, S. Ambs, A. Cimmino,
F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin,
R. L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa,
A. Vecchione, M. Negrini, C. C. Harris and C. M. Croce,
Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 2257–2261.
9 J. Iqbal, Y. Shen, X. Huang, Y. Liu, L. Wake, C. Liu,
K. Deﬀenbacher, C. M. Lachel, C. Wang, J. Rohr, S. Guo,This journal is © The Royal Society of Chemistry 2019
Paper RSC Advances
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
5 
A
pr
il 
20
19
. D
ow
nl
oa
de
d 
on
 5
/9
/2
01
9 
3:
07
:0
8 
PM
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineL. M. Smith, G. Wright, S. Bhagavathi, K. Dybkaer, K. Fu,
T. C. Greiner, J. M. Vose, E. Jaﬀe, L. Rimsza, A. Rosenwald,
G. Ott, J. Delabie, E. Campo, R. M. Braziel, J. R. Cook,
R. R. Tubbs, J. O. Armitage, D. D. Weisenburger,
L. M. Staudt, R. D. Gascoyne, T. W. McKeithan and
W. C. Chan, Blood, 2015, 125, 1137–1145.
10 S. Thakur, R. K. Grover, S. Gupta, A. K. Yadav and B. C. Das,
PLoS One, 2016, 11, e0158946.
11 A. Bunschoten, T. Buckle, J. Kuil, G. D. Luker, K. E. Luker,
O. E. Nieweg and F. W. B. van Leeuwen, Biomaterials, 2012,
33, 867–875.
12 C. Glinge, S. Clauss, K. Boddum, R. Jabbari, J. Jabbari,
B. Risgaard, P. Tomsits, B. Hildebrand, S. Ka¨a¨, R. Wakili,
T. Jespersen and J. Tfelt-Hansen, PLoS One, 2017, 12(2),
e0167969.
13 P. S. Mitchell, R. K. Parkin, E. M. Kroh, B. R. Fritz,
S. K. Wyman, E. L. Pogosova-Agadjanyan, A. Peterson,
J. Noteboom, K. C. O'Briant, A. Allen, D. W. Lin, N. Urban,
C. W. Drescher, B. S. Knudsen, D. L. Stirewalt,
R. Gentleman, R. L. Vessella, P. S. Nelson, D. B. Martin
and M. Tewari, Proc. Natl. Acad. Sci. U. S. A., 2008, 105,
10513–10518.
14 J. A. Weber, D. H. Baxter, S. Zhang, D. Y. Huang,
K. H. Huang, M. J. Lee, D. J. Galas and K. Wang, Clin.
Chem., 2010, 56(11), 1733–1741.
15 Globocan 2012 – Home, http://globocan.iarc.fr/Default.aspx,
accessed 16 August 2017.
16 M. T. Neves-Petersen, T. Snabe, S. Klitgaard, M. Duroux and
S. B. Petersen, Protein Sci., 2006, 15, 343–351.
17 M. T. Neves-Petersen, M. Duroux, E. Skovsen, L. Duroux and
S. B. Petersen, J. Nanosci. Nanotechnol., 2009, 9, 3372–3381.
18 E. Skovsen, T. Neves-Petersen, L. Duroux and S. Petersen,
Advanced Biomedical and Clinical Diagnostic Systems VI,
Proc. of SPIE, 2008, vol. 6848, p. 68480O-1.
19 E. Skovsen, M. Duroux, M. T. Neves-Petersen, L. Duroux and
S. B. Petersen, Int. J. Optomechatronics, 2007, 1, 383–391.
20 M. Duroux, E. Skovsen, M. T. Neves-Petersen, L. Duroux,
L. Gurevich and S. B. Petersen, Proteomics, 2007, 7, 3491–
3499.
21 E. Skovsen, M. T. Neves-Petersen, A. Kold, L. Duroux and
S. B. Petersen, J. Nanosci. Nanotechnol., 2009, 9, 4333–4337.
22 E. Skovsen, A. B. Kold, M. T. Neves-Petersen and
S. B. Petersen, Proteomics, 2009, 9, 3945–3948.
23 S. B. Petersen, A. Kold di Gennaro, M. T. Neves-Petersen,
E. Skovsen and A. Parracino, Appl. Opt., 2010, 49, 5344–5350.This journal is © The Royal Society of Chemistry 201924 P. Jonkheijm, D. Weinrich, H. Schro¨der, C. M. Niemeyer and
H. Waldmann, Angew. Chem., Int. Ed., 2008, 47, 9618–9647.
25 D. S. Wilson and S. Nock, Curr. Opin. Chem. Biol., 2002, 6, 81–
85.
26 B. Johnsson, Anal. Biochem., 1991, 277, 268–277.
27 A. Collioud, J. F. Cle´mence, M. Sa¨nger and H. Sigrist,
Bioconjugate Chem., 1993, 4, 528–536.
28 R. Y. Sweeney, B. R. Kelemen, K. J. Woycechowsky and
R. T. Raines, Anal. Biochem., 2000, 286, 312–314.
29 M. T. Petersen, P. H. Jonson and S. B. Petersen, Protein Eng.,
1999, 12, 535–548.
30 M. T. Neves-Petersen, Z. Gryczynski, J. Lakowicz, P. Fojan,
S. Pedersen, E. Petersen and S. B. Petersen, Protein Sci.,
2002, 11, 588–600.
31 M. T. Neves-Petersen, S. Klitgaard, T. Pascher, E. Skovsen,
T. Polivka, A. Yartsev, V. Sundstro¨m and S. B. Petersen,
Biophys. J., 2009, 97, 211–226.
32 Black Hole Quencher® Dyes|LGC Bioresearch Technologies,
https://www.biosearchtech.com/support/education/
uorophores-and-quenchers/black-hole-quencher-dyes,
accessed 12 December 2017.
33 M. Zuker, Nucleic Acids Res., 2003, 31, 3406–3415.
34 A. Tsourkas, M. A. Behlke, S. D. Rose and G. Bao, Nucleic
Acids Res., 2003, 31, 1319–1330.
35 Thermo Fisher Scientic Inc., Fluorescence SpectraViewer,
https://www.thermosher.com/dk/en/home/life-science/cell-
analysis/labeling-chemistry/uorescence-
spectraviewer.html, accessed 7 November 2017.
36 O. Gonçalves, S. Snider, R. Zadoyan, Q.-T. Nguyen,
H. Vorum, S. B. Petersen and M. T. Neves-Petersen,
Reporters, Markers, Dyes, Nanoparticles, and Molecular
Probes for Biomedical Applications IX, Proc. of SPIE, 2017,
vol. 10079, p. 100790F-1.
37 J. R. Lakowicz, Principles of uorescence spectroscopy,
Academic/Plenum Publishers, New York, 2nd edn, 1999.
38 C. S. Wu, L. Peng, M. You, D. Han, T. Chen, K. R. Williams,
C. J. Yang and W. Tan, Int. J. Mol. Imaging, 2012, 2012,
501579.
39 S. B. Nimse, K. Song, M. D. Sonawane, D. R. Sayyed and
T. Kim, Sensors, 2014, 14, 22208–22229.
40 R. P. Rastogi, A. K. Richa, M. B. Tyagi and R. P. Sinha, J.
Nucleic Acids, 2010, 2010, 592980.
41 A´. Ruiz-To´rtola, F. Prats-Qu´ılez, D. Gonza´lez-Lucas,
M.-J. Ban˜uls, A´. Maquieira, G. Wheeler, T. Dalmay,
A. Griol, J. Hurtado and J. Garc´ıa-Rupe´rez, Biomed. Opt.
Express, 2018, 9, 1717–1727.RSC Adv., 2019, 9, 12766–12783 | 12783
